Literature DB >> 9001438

Neuropeptide Y receptor subtypes.

C P Wan1, B H Lau.   

Abstract

Neuropeptide Y (NPY) is an amidated 36-amino acid peptide with a wide distribution in the central and peripheral nervous system. It can evoke numerous physiological responses by activating specific receptors. Studies using NPY analogs in various model systems and cell types demonstrate different orders of ligand potency and receptor binding affinity. These studies suggest the existence of multiple subtypes of NPY receptors. NPY has been described to bind to at least three different receptors, Y1, Y2 and Y3. NPY has also been shown to interact with sigma receptor in vivo and in vitro. There are indications that more subtypes might exist. Ligand binding studies reveal that Y1, Y2 and Y3 receptors are all G-protein coupled. It is not yet confirmed whether the sigma receptor that interacts with NPY is G-protein coupled. Some studies show that NPY receptors may interact with other classical receptors, including alpha- and beta-adrenoceptors and cholinergic receptors. In the case of alpha- and beta-adrenoceptors, the receptor-receptor interaction is possibly via a pertussis toxin-sensitive G-protein. NPY receptors are coupled to various signal transduction mechanisms including inhibition of adenylate cyclase, and stimulation or inhibition of increases in intracellular Ca2+. Specific links between individual NPY receptor subtype and a particular signal transduction pathway are not established.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 9001438     DOI: 10.1016/0024-3205(95)00041-4

Source DB:  PubMed          Journal:  Life Sci        ISSN: 0024-3205            Impact factor:   5.037


  10 in total

1.  Neuropeptide Y release in the rat spinal cord measured with Y1 receptor internalization is increased after nerve injury.

Authors:  Juan Carlos Marvizon; Wenling Chen; Weisi Fu; Bradley K Taylor
Journal:  Neuropharmacology       Date:  2019-08-02       Impact factor: 5.250

2.  The neuropeptide Y Y1 receptor subtype is necessary for the anxiolytic-like effects of neuropeptide Y, but not the antidepressant-like effects of fluoxetine, in mice.

Authors:  Rose-Marie Karlsson; Jessica S Choe; Heather A Cameron; Annika Thorsell; Jacqueline N Crawley; Andrew Holmes; Markus Heilig
Journal:  Psychopharmacology (Berl)       Date:  2007-09-22       Impact factor: 4.530

3.  Failure of the putative neuropeptide Y antagonists, benextramine and PYX-2, to inhibit Y2 receptors in rat isolated prostatic vas deferens.

Authors:  S Palea; M Corsi; J M Rimland; D G Trist; E Ratti
Journal:  Br J Pharmacol       Date:  1995-11       Impact factor: 8.739

4.  Neuropeptide Y inhibits axonal transport of particles in neurites of cultured adult mouse dorsal root ganglion cells.

Authors:  Hiromi Hiruma; Ayako Saito; Tatsumi Kusakabe; Toshifumi Takenaka; Tadashi Kawakami
Journal:  J Physiol       Date:  2002-08-15       Impact factor: 5.182

5.  Reversal by NPY, PYY and 3-36 molecular forms of NPY and PYY of intracisternal CRF-induced inhibition of gastric acid secretion in rats.

Authors:  M Gué; J L Junien; J R Reeve; J Rivier; D Grandt; Y Taché
Journal:  Br J Pharmacol       Date:  1996-05       Impact factor: 8.739

6.  Sympathetic innervation of human muscle spindles.

Authors:  Dina Radovanovic; Kevin Peikert; Mona Lindström; Fatima Pedrosa Domellöf
Journal:  J Anat       Date:  2015-06       Impact factor: 2.610

Review 7.  Maternal stress and diet may influence affective behavior and stress-response in offspring via epigenetic regulation of central peptidergic function.

Authors:  Annika Thorsell; Daniel Nätt
Journal:  Environ Epigenet       Date:  2016-08-20

8.  Deletion of Neuropeptide Y Attenuates Cardiac Dysfunction and Apoptosis During Acute Myocardial Infarction.

Authors:  Wei Huang; Qianhui Zhang; Hanping Qi; Pilong Shi; Chao Song; Yongsheng Liu; Hongli Sun
Journal:  Front Pharmacol       Date:  2019-10-24       Impact factor: 5.810

9.  Identification of differentially expressed genes in ulcerative colitis and verification in a colitis mouse model by bioinformatics analyses.

Authors:  Lei Shi; Xiao Han; Jun-Xiang Li; Yu-Ting Liao; Fu-Shun Kou; Zhi-Bin Wang; Rui Shi; Xing-Jie Zhao; Zhong-Mei Sun; Yu Hao
Journal:  World J Gastroenterol       Date:  2020-10-21       Impact factor: 5.742

Review 10.  The Role of Neuropeptide Y in Cardiovascular Health and Disease.

Authors:  Cheryl M J Tan; Peregrine Green; Nidi Tapoulal; Adam J Lewandowski; Paul Leeson; Neil Herring
Journal:  Front Physiol       Date:  2018-09-19       Impact factor: 4.566

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.